Elisa Fabbrini
Impact in
-
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Diet, Metabolism, and Disease 9
- Diabetes Treatment and Management 9
- Physiology 24
- Diet and metabolism studies 12
- Adipose Tissue and Metabolism 11
- Co-authors
- Samuel KleinShelby SullivanFaidon MagkosB. Selma MohammedBruce W. PattersonKevin KorenblatAdewole L. OkunadeJ. Christopher Eagon
- Journals
- Obesity (7 papers)Gastroenterology (7 papers)The Journal of Clinical Endocrinology & Metabolism (5 papers)Diabetes (3 papers)Journal of Lipid Research (3 papers)
- Partner nations
- United StatesItalyGreece
In The Last Decade
Elisa Fabbrini
59 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 2.9k
- Epidemiology 3.8k
- Physiology 2.6k
- Biochemistry 490
- Endocrine and Autonomic Systems 393
Countries citing papers authored by Elisa Fabbrini
This map shows the geographic impact of Elisa Fabbrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Fabbrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Fabbrini more than expected).
Fields of papers citing papers by Elisa Fabbrini
This network shows the impact of papers produced by Elisa Fabbrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Fabbrini. The network helps show where Elisa Fabbrini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisa Fabbrini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2019 | 90 | |
| 3 | 2018 | 5 | |
| 4 | Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events Hit paper breakdown → | 2017 | 375 |
| 5 | 2015 | 38 | |
| 6 | 2013 | 227 | |
| 7 | 2012 | 31 | |
| 8 | 2012 | 76 | |
| 9 | 2012 | 155 | |
| 10 | 2010 | 143 | |
| 11 | 2010 | 33 | |
| 12 | Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity Hit paper breakdown → | 2009 | 762 |
| 13 | 2009 | 2 | |
| 14 | 2009 | 11 | |
| 15 | 2008 | 392 | |
| 16 | 2008 | 29 | |
| 17 | 2008 | 72 | |
| 18 | 2007 | 451 | |
| 19 | 2000 | 71 | |
| 20 | 2000 | 163 |
About Elisa Fabbrini
Elisa Fabbrini is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Epidemiology, Endocrine and Autonomic Systems and Family Practice, having authored 60 papers that have together received 7.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), Diet and metabolism studies (12 papers), Adipose Tissue and Metabolism (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Diet, Metabolism, and Disease (9 papers), Diabetes Treatment and Management (9 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Bariatric Surgery and Outcomes (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.9k citations), Epidemiology (3.8k citations), Physiology (2.6k citations), Biochemistry (490 citations) and Endocrine and Autonomic Systems (393 citations). Elisa Fabbrini has collaborated with scholars based in United States, Italy and Greece. Frequent co-authors include Samuel Klein, Shelby Sullivan, Faidon Magkos, B. Selma Mohammed, Bruce W. Patterson, Kevin Korenblat, Adewole L. Okunade, J. Christopher Eagon, Terri Pietka and Nada A. Abumrad. Their work appears in journals such as Obesity, Gastroenterology, The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.